High rate of adverse drug reactions with a novel tuberculosis re-treatment regimen combining triple doses of both isoniazid and rifampicin

Objectives: High-dose rifampicin (R) and isoniazid (H) are known to be safe but were not yet combined in a single regimen. The primary objective of the TRIple-DOse RE-treatment (TRIDORE) study is to determine whether a 6-month firstline regimen with triple dose of both R and H (intervention arm; 6R3...

Descripció completa

Dades bibliogràfiques

Autors principals:	Mahamadou Bassirou Souleymane, Sani Kadri, Alberto Piubello, Achilleas Tsoumanis, Alphazazi Soumana, Hamidou Issa, Abdoulaziz Kabirou Amoussa, Armand Van Deun, Lutgarde Lynen, Bouke Catherine de Jong, Tom Decroo
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2023-08-01
Col·lecció:	International Journal of Infectious Diseases
Matèries:	High rifampicin High isoniazid Adverse drug reactions
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S1201971223005507
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!